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Introduction: Blast injury to brain, a hundred-year old problem with poorly characterized neuropathology, has
resurfaced as health concern in recent deployments in Iraq and Afghanistan. To characterize the neuropathology of
blast injury, we examined the brains of veterans for the presence of amyloid precursor protein (APP)-positive axonal
swellings typical of diffuse axonal injury (DAI) and compared them to healthy controls as well as controls with
opiate overdose, anoxic-ischemic encephalopathy, and non-blast TBI (falls and motor vehicle crashes).
Results: In cases with blast history, we found APP (+) axonal abnormalities in several brain sites, especially the
medial dorsal frontal white matter. In white matter, these abnormalities were featured primarily by clusters of
axonal spheroids or varicosities in a honeycomb pattern with perivascular distribution. Axonal abnormalities
colocalized with IBA1 (+) reactive microglia and had an appearance that was distinct from classical DAI encountered in
TBI due to motor vehicle crashes. Opiate overdose cases also showed APP (+) axonal abnormalities, but the intensity of
these lesions was lower compared to cases with blast histories and there was no clear association of such lesions with
microglial activation.
Conclusions: Our findings demonstrate that many cases with history of blast exposure are featured by APP (+)
axonopathy that may be related to blast exposure, but an important role for opiate overdose, antemortem anoxia,
and concurrent blunt TBI events in war theater or elsewhere cannot be discounted.
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Blast injury to brain, the signature injury of recent
conflicts in Iraq (Operation Iraqi Freedom; OIF) and
Afghanistan (Operation Enduring Freedom; OEF), is a
hundred-year old problem that began with the introduc-
tion of trinitrotoluene in artillery shells in WWI [1].
Based on recent Department of Defense estimates [2],
there are presently upwards of 250,000 OEF/OIF veterans
with traumatic brain injury (TBI) history, many of them
due to blast, and the importance of understanding the
long-term sequelae of blast TBI cannot be overestimated.
Blast TBI is complex and incorporates the direct effects
of overpressure wave (primary injury), the gunshot-like* Correspondence: koliat@jhmi.edu
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unless otherwise stated.effects of debris and shrapnel showering the head (second-
ary injury), the fall impact from translocation of the body
by the overpressure wave (tertiary injury), as well as flash
burns from the intense heat and asphyxiation or inhalation
injuries [3]. Concurrent lesions to other organs leading to
respiratory or heart failure or severe hemorrhage may
contribute to brain hypoxia/ischemia. Factors that further
complicate the long-term outcomes of blast injury are the
complex dynamics of blast wave propagation, the mitigat-
ing or potentially enhancing effects of personal protective
equipment [3], the number of blast exposure events [4,5],
as well as the associated comorbidities of PTSD, chronic
pain and substance abuse [6-8].
Despite the hundred-year long history of blast TBI
and its significance for military medicine and beyond, its
neuropathology has been very poorly characterized [9].
Part of the problem is lack of sufficient high-quality
autopsy material, especially from long-term survivors of
blast injuries. Recent reports from animal models of blastis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[10,11], but the occurrence or significance of axonal injury
in the brains of human subjects with blast exposure is still
a matter of debate [4,12].
Diffuse Axonal Injury (DAI) is a common event in
human TBI, ranging from mild (concussive) to severe,
including lethal, TBI [13-17]. DAI is a convention used
for multifocal injury of long axons associated with im-
pulse loading and encountered primarily in humans
and other gyrencephalic animals [18]. DAI is featured
by progressive axolemmal and axoskeletal alterations
leading from axonal swellings (bulbs) to axotomy and
the formation of retraction balls [19,20]. DAI was initially
identified with silver degeneration methods [21]; however,
because many neuronal proteins, including neurofilament
proteins and amyloid precursor protein (APP) accumulate
in damaged axons, immunohistochemistry (IHC) for
these proteins has largely replaced silver methods in re-
cent studies [14,19,22-24]. This paper directly docu-
ments the presence of APP (+) DAI in the brains of
veterans with blast exposure history and raises impor-
tant issues of interpretation and differential diagnosis.
Materials and methods
Subjects
Subjects were veterans with prior history of blast (n = 5;
all males; ages 23-38, average 28; three of these subjects
had died by opiate and/or alcohol overdose); controls with
history of opiate overdose (n = 6; 2 males, 4 females; ages
18-48, average 25) or anoxic-ischemic encephalopathy
(n = 6; 3 males, 3 females; ages 16-45, average 28); TBI
controls with history of motor vehicle crashes (MVC)
or falls (n = 5; all males; ages 18-51, average 31); and
controls without history of TBI, opiate overdose or
anoxic-ischemic encephalopathy (n = 7; 4 males, 3
females; ages 21-70, average 36) (Table 1). Brains were
provided through the Armed Forces Institute of Pathology
(AFIP) autopsy service or the Johns Hopkins Brain
Resource Center (BRC). Blast cases included in this
study did not have, as far as we know, contusional
injuries. Essential demographic and clinical data as well
as main neuropathological findings are summarized in
Table 1. In addition, we used cases with Alzheimer’s
disease and dementia pugilistica from the BRC collec-
tion as positive controls for phosphorylated tau IHC
(see below).
Preparation of tissues, histology and IHC
Brains were immersion fixed in 10% formalin for two
weeks at room temperature. Coronal tissue slabs were
processed and embedded in paraffin and serial 10 μm-
thick sections from standard blocks through frontal
parasagittal cortex, anterior corpus callosum, hippocam-
pus, thalamus, dorsolateral pons at the level of thesuperior cerebellar peduncle and cerebellar cortex
were stained with hematoxylin and eosin, Cresyl violet,
Masson’s trichrome, and processed for the IHC detection
of: amyloid precursor protein (APP) (using a monoclonal
antibody against the amino-terminus of APP [clone
22C11; MAB348 from Millipore, Temecula, CA] con-
centrated 1:200) as a marker of abnormal axons; glial
fibrillary acidic protein (using a rabbit monoclonal anti-
body against the C-terminal of GFAP [clone EP672Y;
04-1031 from Millipore] concentrated 1:500) as marker
of astrocytes; ionized calcium- binding adaptor mol-
ecule 1 antibody (IBA1; a rabbit polyclonal antibody
[CP290A from Biocare Medical LLC, Concord, CA]
concentrated 1:300) as microglial marker; and mixed
phosphorylated neurofilament epitopes (a mouse mono-
clonal antibody against phosphorylated neurofilament H
and, to a limited extent, neurofilament M [SMI-310R;
Covance, Emeryville, CA] concentrated 1:200) as generic
axonal marker.
Sections through the frontal cortex and hippocampus
from all blast cases were also processed for phosphory-
lated tau IHC with antibodies AT8, PHF1, and CP13 and
the conformational tau antibody MC1. AT8 is directed
against tau pS202 (MN1020; Thermo Scientific Inc.,
Rockford, IL); PHF1 is directed against tau pS396 and
pS404; CP13 is directed against tau pS202 and pT205; and
the conformational antibody MC1 is directed against the
third microtubule binding domain of tau (amino acids
313 to 322) and recognizes the conformation formed by
N-terminus amino acid 7 to 9 and amino acids 313 to
322 in neurofibrillary tangles, but not fetal Alz-50-
reactive clone 1. Antibodies PHF1, CP13 and MC1 were
provided by Dr. Peter Davies, Albert Einstein College of
Medicine, Bronx, NY. All antibodies were used in 1:200
concentration. Normal IgG from the species of origin of
the primary antibodies was used as negative control.
Immunoperoxidase IHC was performed essentially as
described in Hedreen and Koliatsos (1994) [25] with some
modifications. Paraffin sections were deparaffinized and
rehydrated by incubation at 60°C for 30 minutes followed
by sequential treatments with xylene, 100% and 95% etha-
nol. Endogenous peroxidase activity was blocked with
hydrogen peroxide. Three percent (w/v) normal IgG in
TBS including 0.1% Tween 20 solution was used for
blocking and antibody incubation. The appropriate bio-
tinylated goat anti-primary antibody IgGs in concentra-
tions 1:250 to 1:400 were used as secondary antibodies.
A standard avidin-biotin peroxidase reaction (PK-6100,
Vector Lab. Inc., Burlingame, CA) followed by diami-
nobenzidine (DAB) incubation were used to visualize
immunoreactive epitopes. For double IHC of IBA1 or
GFAP with APP, APP immunoreactivity was detected
first as stated previously and IBA1 or GFAP immunore-
activity was detected by ImmPRESS-AP Anti-rabbit IgG
Table 1 Demographic, clinical and neuropathological signatures of subjects included in this study
Case Age/
Gender
Cause of death Combat
history




1 38M Multi-organ failure Yes Blast 2 mo PTD1 No Purkinje Cell Degeneration
2 23M GSW of head Yes Blast 11 mo PTD2 No None
3 26M Methadone overdose Yes Blast 1 yr PTD Yes Purkinje Cell Degeneration
Concussion due to
Assault 2 mo PTD3
4 28M Methadone overdose Yes Blast 4 yrs PTD4 Yes CA1 Cell Degeneration
Purkinje Cell Degeneration
5 25M Alcohol and Opiate overdose Yes Blast PTD unknown Yes Purkinje Cell Degeneration
6 20M Methadone overdose No No5 Yes None
7 24M Opiate overdose No No Yes CA1 Cell Degeneration
Acute brain swelling Purkinje Cell Degeneration
8 48F Methadone overdose Acute hypoxic-
ischemic encephalopathy <24 h duration




9 38F Methadone and cocaine overdose
Cerebral edema Early hypoxic-ischemic
encephalopathy 12 h duration
No No Yes CA1 Necrosis Neocortical and
Entorhinal Necrosis
10 32F Opiate overdose Cerebral edema Hypoxic-
ischemic encephalopathy 48 h duration
No No Yes CA1 Necrosis Neocortical
Necrosis
11 18F Opiate and antidepressant overdose No No Yes N/A
12 22F Acute hypoxic-ischemic encephalopathy
27 d duration
No No No CA1 Necrosis Purkinje and Deep
Nuclei Cell Necrosis Cortical
Necrosis Basal Ganglia
Cell Necrosis
13 26M Cardiac arrhythmia No No6 No CA1 Cell Degeneration
Acute hypoxic-ischemic encephalopathy Purkinje Cell Degeneration
14 19M Hypoxic-ischemic encephalopathy Yes Blast 19 d PTD7 No CA1 Degeneration
Purkinje Cell Degeneration
Cortical cell death
Basal ganglia cell death
15 16F Hypoxic-ischemic encephalopathy
(general anesthesia)




16 45F Hypoxic-ischemic encephalopathy
Pneumonia Cardiac arrhythmia
<24 h duration
No No No CA1 Necrosis
Purkinje Cell Necrosis
Neocortical Necrosis
17 39M Hypoxic-ischemic encephalopathy
Asphyxia 4 d duration




18 22M Extensive traumatic brain injury No TBI due to MVA
12 d PTD8
No Purkinje Cell Degeneration
Brain hemorrhage
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Table 1 Demographic, clinical and neuropathological signatures of subjects included in this study (Continued)
19 21M Intra cerebral hemorrhage No TBI due to Fall 4 d
PTD9
No CA1 Cell Degeneration
Brain herniation Purkinje Cell Degeneration
20 18M Extensive TBI No TBI due to MVA 2 d
PTD
No N/A
21 42M Extensive TBI No MVC 6 d PTD No N/A
22 51M Extensive TBI No MVC 3 h PTD No N/A
23 21M Sudden death Heavy lungs
Negative toxicology
No No No None
24 28M Sudden death No No No None
Normal autopsy
Negative toxicology
25 21M Sudden death No No No CA1 Cell Degeneration
Stenosis of the coronary ostia Purkinje Cell Degeneration




27 70F Sudden death No No No CA1 Cell Degeneration
Cardiac arrhythmia Purkinje Cell Degeneration
28 26M Heart attack No No No None
29 48F Heart attack No No No None
1IED; Other clinical problems: Burns 45% TBA; Blast lung; Lung inhalational injuries; Secondary bacterial and fungal infections, 2Multiple IED; Other clinical
problems: PTSD, 3(IED) with noncontusional ejection 10 ft past explosion Other clinical problems: PTSD; Cognitive disorder secondary to TBI; Alcohol abuse, 4Other
clinical problems: Postconcussive syndrome; PTSD; Depression; Adjustment disorder, 5Other clinical problems: Adjustment disorder with depression and anxiety;
Migraine headaches, 6Other clinical problems: Multiple substance abuses, including inhalants and alcohol, 7IED; Other clinical problems: Chest injury; Ruptured
spleen; Cardiac arrest, 8Related clinical findings: Multiple skull fractures; right frontal and temporal lobe contusions, 9Related clinical findings: Skull fracture; Left
frontal/temporal contusions; subdural hematoma, PTD: Prior to death, CA1: Cornu ammonis 1 area in hippocampus, GSW: Gunshot wound, IED: Improvised
explosive device, PTSD: Post-traumatic stress disorder, TBI: Traumatic brain injury, MVA: Motor vehicle accident, TBA: Total body area.
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kit (SK-5300), both from Vector Lab. In some cases, we
also performed silver staining with a variation of the
Gallyas procedure using NeuroSilver™ Kit II (PK301A)
from FD NeuroTechnologies (Ellicott City, MD).
Counts of APP (+) axonal swellings in cases with blast
histories or methadone overdose
Because the vast majority of cases with blast histories
had died of opiate overdose, the relationship between
blast exposure and APP (+) axonal pathology was fur-
ther studied by comparing between cases with blast
histories and cases with opiate overdose prior to death.
Axonal swellings were visualized and counted on APP-
immunostained sections of the superior frontal and
cingulate gyri. The parasagittal white matter in these
areas was outlined on one representative coronal sec-
tion per case of subjects exposed to blast (n = 4) and
subjects who died from opiate overdose (n = 4). The
magnitude of APP (+) axonal pathology was measured
with the areal fraction fractionator probe [26] using
the Stereo Investigator software (MicrobrightField Inc.,
Williston, VT). The fractional area of APP (+) axonal
swellings was generated per case and then combined inthe blast and opiate overdose groups that were further
compared using a student’s t-test.
Results
APP (+) axonal abnormalities in subjects with blast history
In all cases with history of blast exposure except one (Case
2), the most consistent finding was APP-immunoreactive
axonal varicosities or spheroids in the medial (parasagittal)
frontal white matter, primarily in the superior and middle
frontal and cingulate gyri (Figure 1). These lesions clus-
tered in circular or semi-circular formations at short dis-
tances (50-200 μm) from blood vessels and frequently
coalesced in irregularly shaped lattices forming honeycomb
patterns (Figure 1a-b). Similar patterns were often seen in
the white matter of the anterior and middle temporal lobe.
No parietal lobe tissues were available for review. The one
case with blast history that did not show APP (+) axonal
abnormalities in medial frontal white matter or elsewhere
in the brain (Case 2) had a history of exposure to multiple
IEDs and died from gunshot wound to the head (Table 1).
In some cases with blast histories, groups of abnor-
mally swollen APP (+) axons and axon bulbs were also
encountered in the corpus callosum (Additional file 1:
Figure S1 for Case 3 but also Figure 2 for Case 1), the
Figure 1 The typical honeycomb pattern of APP (+) staining in the superior frontal gyrus of an index case with a history of blast injury
(Case 3, Table 1). (b) and (c) are enlargements of the blocked areas in (a) and (b), respectively. This case had blast exposure 1 year before death and
a concussion from assault 2 months prior to death. Note the groups of tens-hundreds of axonal spheroids in the deep white matter of frontal lobe.
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cerebellum, axonal swellings were often seen in the deep
white matter next to deep nuclei and also in the form of
classical retraction balls in the granule cell layer next to
Purkinje cell bodies. These retraction balls were eosino-
philic, argyrophilic, and APP-immunoreactive, and were
also filled with phosphorylated neurofilaments (Additional
file 2: Figure S2 for Case 3). One of these cases, e.g. the
one illustrated in Additional file 1: Figure S1 and Additional
file 2: Figure S2, had suffered traumatic events other than
blast relatively near the time of death. APP (+) axonal
swellings were occasionally encountered also in internal
capsule, striatopallidal pencils, and thalamic striae.
The comparison of sections immunostained with
APP and adjacent sections stained with Masson’s tri-
chrome in regions with honeycomb pattern of axonal
lesions shows that APP (+) perivascular abnormal-
ities are associated with arterioles, but not venules
(Figure 3).APP (+) axonal abnormalities in subjects with history of
opiate overdose, anoxic-ischemic encephalopathy and
non-blast TBI
Because 3 out of 4 blast cases with APP (+) axonal swell-
ings had died of opiate overdose (Table 1), 6 additional
cases with opiate overdose without blast exposure were
analyzed as controls. In 5 out of 6 subjects, we observed
a few APP (+) axonal abnormalities in the medial frontal
white matter, corpus callosum and the internal capsule
(Figure 4), but these pathologies were significantly less
pronounced compared to the ones in blast injury cases. In
one case of an 18-year old female (Case 11) who died from
mixed overdose with antidepressants and opiates, we found
extensive axonal abnormalities in patches throughout the
white matter of frontal cortex. Based on the mixed nature
of intoxication that may be associated with regulatory
APP events [27] this brain was not included in the opiate
overdose group for further stereological analysis, but
was illustrated in supplementary figures (Additional file 3:
Figure 2 Sections immunostained for concomitant localization of APP and IBA1 epitopes in representative cases of MVC (Case 21; a-b),
blast (Case 1; c-d), and opiate overdose (Case 7; e-f). APP (brown) and IBA1 (blue) was detected sequentially by DAB and Vector blue, respectively,
as described in Methods. Note that, in MVC (a-b) and blast (c-d) APP (+) swellings and bulbs colocalise with deramified or phagocytic microglia, whereas
in opiate overdose (e-f) they do not. Panels b, d, and f are magnifications of framed areas in a,c, and e, respectively. Size bars: 50 (a, c and e) and 100
(b, d, and f) μm.
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abnormalities in frontal cortex with stereology, there were
significant differences between the blast (n = 4) and metha-
done (n = 4) groups (P = 0.0195; Figure 5). The honeycomb
pattern of axonal injury with perivascular distribution
(Figure 1) was not evident in methadone overdose cases.
In cases with anoxic-ischemic encephalopathy, APP
staining of axons was extremely variable. Two cases of
young adults showed rare APP (+) fiber abnormalities in
medial frontal white matter and temporal lobe or brain
stem (Cases 12 and 13), whereas four other cases were
negative for APP signal in frontal lobe. The brain of a
16-year old patient (Case 15) who died in the course of
anesthesia and had brain edema with herniation showed
dense APP (+) fibers in brain stem, cerebellar white mat-
ter, medial temporal lobe (angular bundle), and internal
capsule/striatopallidal pencils, but no staining in medial
frontal white matter. We also reviewed two cases with
exposure to methadone overdose at ages 2 and 3 (not
included in Table 1). Both had medial cortical necrosisand displayed APP (+) long fiber swellings coursing
vertical to the white-gray matter border and along the
longitudinal axis of the gyrus that was different from the
abnormalities seen in blast and opiate overdose material.
Cases 18 and 19 with cerebral contusions demon-
strated axonal pathology primarily at the border of the
contusion (Additional file 4: Figure S4); none had APP
(+) abnormalities in the medial frontal white matter.
Cases 20 and 21 with histories of MVC showed large
numbers of abnormal axons with swellings and axon bulbs
cursing in multiple areas, especially in the medial frontal
white matter and anterior corpus callosum, without clear
association with blood vessels (Additional file 5: Figure S5
for Case 20). No evident APP (+) axonal abnormalities were
seen in controls with negative neuropsychiatric histories.
As shown in Figures 6 and 7, the microscopic appear-
ance of axonal abnormalities is different among cases
with histories of motor vehicle crash (the classical sce-
nario causing DAI) versus blast versus opiate overdose.
In coronal sections like the ones used in this study,
Figure 3 Perivascular distribution of APP-immunoreactive axon
abnormalities demonstrated here on adjacent sections, one of
which (top) was processed for APP immunohistochemistry and
the other (bottom) with Masson trichrome stain (images taken
from Case 3). Numbers indicate corresponding blood vessels. Note
that axonal abnormalities encircle aniline blue (+) thick-walled vessels
representing arterioles (#1, 3, 5), but not thin-walled vessels that are
venules (#2, 4). (4) is not evident on top section and only its position
was marked as such. Size bars: 50 μm.
Figure 4 APP (+) axonal abnormalities in the frontal lobe of a
representative patient without history of blast who died as a
result of opiate overdose (Case 9, Table 1). Although there are
occasional clusters of axonal swellings (arrows, a), most cases of
observed abnormalities are less conspicuous (arrows, b). Insets
represent magnifications of areas marked with an asterisk. Size
bars: 10 μm.
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thick with prominent undulations and classical axon
bulbs; in the case of opiate overdose, axonal abnormalities
are thin and straight, with multiple varicosities in the
course of a single axon; in blast cases, axonal abnormal-
ities fall in-between classical DAI and opiate overdose
cases and feature prominent varicosities and spheroids
(Figure 6 and, in further magnification, Figure 7).
Neuroinflammatory responses and other neuropathologies
To explore the regional association of axonal abnormalities
with neuroinflammatory responses in the brains of blast
cases, we performed IHC for the microglial marker IBA1
or the astrocytic marker GFAP and compared such label-
ing with immunolabeling for APP on same or adjacent
sections. Figure 8 shows evidence of colocalization of IBA1(+) deramified/hypertrophic microglia with patches of ab-
normal APP (+) axons in the corpus callosum of an index
case with blast history (Case 1). The best evidence of colo-
calization of APP (+) axonal abnormalities with activated
microglia in blast cases is shown in double-labeling pre-
parations as the one illustrated in Figure 2c-d (Case 1). A
similar colocalization of hypertrophic, phagocytic microglia
with APP (+) axonal abnormalities is seen in DAI asso-
ciated with MVC (Figure 2a-b; Case 21). On the other
hand, there is no evidence of microglial activation next to
abnormal axons in cases of opiate overdose (Figure 2e-f;
Case 7). In contrast to the colocalization of APP (+) axonal
abnormalities with activated microglia in blast and MVC
cases, there was no clear evidence for colocalization of
such abnormalities with GFAP (+) reactive astrocytes.
Gross measures of hypoxia-ischemia were variable in
our blast material; one out of five cases showed hippocam-
pal CA1 degeneration, 4 cases showed apparentreduction
Figure 5 Stereological areal fraction analysis of APP-positive
axonal injury signal in blast (n = 4) and methadone (n = 4)
cases. Coronal sections through the frontal lobe were stained by
APP N-terminal antibody (see Materials and Methods). Axon injury
signal was counted (a) and analyzed by two-tail student’s t-test (b).
Difference between blast and methadone cases was significant at
P value 0.0195.
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showed cortical necrosis. In comparison, 4 out of 6 cases
of methadone overdose showed CA1 degeneration or ne-
crosis, 2 cases showed Purkinje cell degeneration or ne-
crosis and 3 cases showed cortical necrosis. On the other
hand, all 6 cases of hypoxic-ischemic encephalopathy
showed CA1 and Purkinje cell degeneration or necrosis, 5
cases showed cortical necrosis and 4 cases showed basal
ganglia necrosis (Table 1). The severity of anoxic-
ischemic changes in these three groups of cases appears
to bear no association with the severity of axonal abnor-
malities in the medial frontal white matter.
To explore the possibility that blast exposure is asso-
ciated with tauopathy as suggested in a recent study
[28], we processed sections of the frontal and temporal
lobes of 5 blast cases with IHC for distinct phosphory-
lated and conformational tau epitopes using antibodies
AT8, CP13, PHF1 and MC1. We did not detect a posi-
tive signal in any of these blast cases (Additional file 6:
Figure S6), including Case 4 that survived 4 years after
blast, despite the fact that all antibodies reacted withneurofibrillary tangles in control AD cases (data not
shown) and all antibodies except MC1 stained tangles
in an established case of dementia pugilistica (Additional
file 6: Figure S6a-f).
Discussion
Relevance of findings and comparison with other lines of
research
Our findings show that brains of subjects with a history
of blast exposure are featured by widespread APP (+)
axonal abnormalities. In the cortical white matter, these
abnormalities appear primarily as clusters of small
axonal varicosities or spheroids. This form of DAI differs
from classical DAI due to MVC or axonal degeneration
associated with contusions. Although most of the brains
with blast histories examined here belong to subjects
who died from opiate overdose, the pathological patterns
described here differ from axonal lesions in subjects that
died from overdose without history of blast exposure.
Differences are based on density, their degree of associ-
ation with neuroinflammation, and also some micro-
scopic features of axonal abnormalities. It is possible
that prior blast or blunt TBI exposure and particular an-
temortem circumstances, such as opiate overdose and/or
anoxia, may act in synergy to produce the honeycomb
pattern of APP staining seen in Figure 1. The focus of
this study was APP (+) axonopathy without any claims
as to whether this is a primary or secondary outcome
of blast. Although traumatic axonopathy has been con-
firmed by several groups working on animal models of
blast TBI [10,11,29], some investigators place emphasis
on microvascular pathology [30,31].
To our knowledge, this is the first direct evidence of
DAI in the brains of veterans with prior blast exposure.
Indirect evidence consistent with the presence of DAI
comes from diffusion tensor imaging (DTI) studies on
soldiers with blast histories. Mac Donald et al have
reported abnormal DTI signal in the middle cerebellar
peduncle, cingulum, and orbitofrontal white matter of
U.S. military personnel within 90 days of injury [4], but
only middle cerebellar peduncle abnormalities were
replicated in a follow-up report focusing on pure pri-
mary blast injury [32]. In another DTI study, Jorge et al
reported on regions of reduced low fractional anisot-
ropy in the brains of OIF/OEF veterans with mild TBI.
These lesions had a predilection for the corpus callosum
and, less so, the cerebellum, and could be caused by
axonal injury [12]. Another DTI study in veterans of
OIF/OEF with histories of mild TBI showed similar
patterns [33]. Yet other investigators failed to find DTI-
based abnormalities in veterans with mild-to moderate
blast TBI [34].
Anatomical regions highlighted in DTI studies partially
overlap with the regional distribution of DAI lesions
Figure 6 Microscopic features of APP (+) axon abnormalities in motor vehicle crashes (a-c), blast (d-f) and opiate overdose (g-i) in
typical cases. a is taken from Case 20, b and c from Case 21, d from Case 4, e from Case 5, f from Case 3, g from Case 9, h from Case 7 and i from
Case 6. Insets represent enlargements of indicated areas. Note differences in size of axons among the three types of injury and also the prominence of
undulations and axon bulbs in cases of motor vehicle crash (a-c). Portions of the insets are further magnified in Figure 7. Size bars: 50 μm.
Figure 7 Further magnification of areas indicated with arrows in Figure 6. Arrangement of panels is exactly as in Figure 6. These images
illustrate in greater detail the anatomical differences of injured axons among classical traumatic DAI (a and b from Case 20, c and d from Case 21), blast
(e and f from case 4, g from Case 5, h from Case 3), and opiate overdose (i and j from Case 9, k from Case 7, l from Case 6). Size bars: 20 μm.
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Figure 8 Adjacent sections through the anterior corpus callosum of a typical blast case (Case 1; Table 1) immunostained with an
axonal injury marker (APP; a-b) and microglial marker (IBA1; c-d). b is enlargement of bracketed area in a and shows, in greater detail,
abnormally swollen axons traveling in various directions. d is an enlargement of bracketed are in c taken through the border between healthy
tissue and a patch of axonopathy. Insets in d are magnifications of microglial profiles indicated with arrows. Note the correspondence of
axonopathy (a) with neuroinflammation (c) in the same patch of tissue and the transition between ramified and deramified/round microglia in
the border between reactive and non-reactive tissue in (d). In Figure 2e-f, note that microglia has resting cytology and there are no appreciable
differences between areas with APP (+) axonopathy and areas without. Size bars: 50 (a and c) and 20 (b and d) μm.
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ment of the hemispheres than the cerebellum, but our
limited sampling does not allow definitive conclusions.
Furthermore, it is unclear how the several mm-diameter
“potholes” of limited fractional anisotropy described by
Jorge et al [12] might correspond to the much smaller
honeycomb islands identified in the present study. Blast
injury simulation modeling reveals maximal shearing
stress in a few brain sites including orbitofrontal, brain
stem and frontal parasagittal regions [35] and predicts,
in part, neuropathological patterns observed here. The
selective vulnerability of certain long CNS tracts to
primary blast is supported by recent animal studies
demonstrating traumatic axonal injury in the corpus
callosum, corticospinal, cerebellar, and lemniscal path-
ways [10,11]. The involvement of these tracts may be
related to the distribution and intensity of shearing
stress and other types of mechanical distortion in the
brain, although such biomechanical factors may oper-
ate differently in the human versus rodent CNS [35].
The peri-arterioral distribution of axonal pathology in
our blast cases may be due to similar factors, for
example shearing stress of axons may be especially in-
tense in the white matter enveloping the mechanically
stiff arterial environment.TBI-associated DAI versus opiate-overdose axonopathy
The majority of blast cases with APP (+) axonal swell-
ings had died of opiate overdose. Brains of patients who
died of opiate overdose without history of blast exposure
did show evidence of axonopathy, but some features of
blast-associated axonal injury set it apart from the injury
associated with opiate overdose. First, the severity of
APP (+) axonopathy is greater in blast cases compared
to cases with opiate overdose without blast history. Sec-
ond, there is close relationship of APP (+) axonal abnor-
malities with activated microglia in blast cases, even
4 years after the index event; this finding suggests the
presence of neuroinflammation in regions with abnormal
axons that takes days to evolve and may not be consist-
ent with agonal events related to overdose as sufficient
causes of blast-related axonopathy. Third, there are
some microscopic differences between abnormal axons
in cases of opiate overdose and cases with history of
blast: the former present primarily as beaded, relatively
thin axons, whereas the latter usually present as larger
varicosities or spheroids. According to some studies,
granular appearance of axons may represent advanced
axonal degeneration with axon fragments persisting
months or years after blast, in tandem with enduring
neuroinflammation [36-38]. The longevity of axons or
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neurobiology of disease [39] and some of the molecular
mechanisms have been revealed in Wld mice [40,41].
Fourth, axonal abnormalities related to opiate overdose do
not show the prominent peri-arteriolar honeycomb distri-
bution of blast-associated axonal lesions.
Opiate overdose may contribute to the axonal abnor-
malities observed in blast cases. For example, primary
blast injury may have caused endangerment of the axons
or regional neuroinflammation that was further compli-
cated by chronic use of opiates or by protracted agonal
events associated with opiate overdose and culminated
in the observed honeycomb pattern. In this scenario,
honeycomb varicosities or spheroids may represent
“fresh” low-grade axonopathy [42] in primed axons or in
regions primed by chronic neuroinflammation, both
from the original blast. Non-primary blast injury may
also have contributed to the axonal abnormalities ob-
served here, including tertiary injuries from concussions
and quaternary thermal injuries. Traumatic events such
as blunt concussions suffered outside the combat theater
in the weeks prior to death may have also added to this
pattern.
The association between opiate overdose and axonopa-
thy has been reported before [43-45] and was largely as-
cribed to hypoxia. In our case series, brains with classical
anoxic-ischemic encephalopathy had negligible axonal
injury, a pattern consistent with previous studies [46].
Furthermore, rodents dying of methadone overdose do
not show APP (+) axonal swellings (Leri, Koliatsos and
Ryu, unpublished observations), despite the fact that
traumatic axonal injury can be induced in a variety of
rodent TBI models [11,47-51]. Of course, the absence of
axonal injury in severe anoxic-ischemic encephalopathy
does not preclude the presence of axonopathy in the
case of prolonged milder hypoxia. At the same time, the
absence of axonopathy in rodent models of opiate over-
dose does not preclude the occurrence of such in the
course of opiate overdose in humans. Beading of axons
in the absence of bulbs seen in opiate and other over-
dose cases may be associated with nodal or paranodal
events, including swelling of mitochondria, as shown in
experimental anoxic nerve injury [52]. The role of opi-
ate overdose and/or anoxia in the evolution of honey-
comb axonopathy in blast cases is also suggested by
Case 2 that, although clearly exposed to blast, did not
show APP (+) axonopathy. This patient died from self-
inflicted gunshot wound to the head that we assume
caused instant death, a condition incompatible with
prolonged agonal state and brain anoxia. The presence
of honeycomb axonopathy in Case 1 that had died of
multi-organ failure, but not opiate overdose, is also
compatible with a role of anoxia in the establishment of
such lesions.We propose that blast exposure and agonal hypoxia
(primarily caused by opiate overdose in our series)
should be viewed as interactive or synergistic factors in
the genesis of the honeycomb axonopathy observed
here. It is difficult to say whether the spherical lesions
represent residues of progressively degenerating axons
from the original blast event or, rather, fresh low-grade
lesions caused by prolonged hypoxia in axons primed at
the time of the blast. Such questions address the broader
problem of the cumulative effect of multiple injurious
impacts to the brain and, to some extent, can be mod-
eled and studied in animals.
Blast history and tauopathy
Two recent reports [28,53] have demonstrated the pres-
ence of tauopathy in the brains of five veterans with
prior blast exposure and one of these studies [28] mod-
eled this finding on single-blast exposure of mice featur-
ing free head movement. The same study [28] reported
axonal and microglial pathology next to tau deposits that
are not directly comparable to our findings. Using an
identical panel of phosphorylated tau antibodies as
Goldstein et al [28], we were unable to confirm tau
hyperphosphorylation in any of our 5 blast subjects,
including a case that had survived 4 years after blast.
Neuropsychiatric symptoms in our subjects were broadly
similar to these of the other reports and involved a com-
bination of PTSD, depression and cognitive difficulties.
The varied findings may be due to a number of reasons
including a limited number of sampling sites in our
material, differences in tissue processing such as length
of fixation, and differences in average time interval
between blast events and death that was somewhat lon-
ger in the case series of Goldstein et al [28]. At the very
least, the issue of tauopathy after military blast history is
very complex and findings from one case or case series
cannot be readily generalized. As in the case of other
comparisons made here, there is great need for several
types of controls, including adequate sampling of young
or middle-aged subjects without blast or TBI history.
Clinical considerations and problems in establishing
cause and effect
Although it is risky to draw clinical conclusions based
on pathological autopsy material, the strong frontal and
paralimbic patterns of axonal injury reported here may
shed light into the problem of chronic executive and
attentional difficulties experienced by chronic survivors
of blast TBI [54]. On another clinical subject, the non-
intentional overdose by methadone, used as a popular
analgesic by veterans, is a very important problem in
retired military personnel [55,56] and it is possible that
it may exacerbate pre-existing axonal injuries. This
important issue should be clarified with further research.
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from the complex cohort of OIF/OEF veterans should
take into account a life style often featured by repeat
combat and non-combat TBI and substance abuse/over-
dose. As highlighted in the previous sections of Discus-
sion, these events may act in synergy to cause axonopathy.
Time parameters are also important. Acute and chronic
DAI have different microscopic appearances [36,38] and,
at the same time, survival time also reflects TBI severity:
Lethal TBI by definition involves brief survival and causes
severe acute axonopathy featured by prolific axonal swell-
ings with bulbs; mild TBI is not a cause of death per se
and is naturally associated with fewer axonal lesions that
fade over time or persist as granular residues. Thus, sur-
vival time may play an important role in the differences
seen between DAI due to MVC and DAI in subjects with
blast histories (Figures 6 and 7).
Our findings provide the groundwork for a fresh look
into the problem of blast injury to brain, and stress the
fact that DAI may be shared between blast and other
types of acceleration injury to brain, although patho-
logical details appear to be different. Importantly, our
study underlines the complexity of cases with blast history
that come to autopsy and the need to engage several dif-
ferent types of controls, while recognizing the possibility
of interacting pathogenic factors. Simple blast cases fea-
turing solely primary blast events without secondary,
tertiary etc components and not associated with other
combat or non-combat TBI or substance abuse comor-
bidities or antemortem hypoxia may lend themselves to
more straightforward clinico-pathological analyses, but
such cases are probably a small fraction of the TBI
problem in the OIF/OEF veteran cohort and are ex-
tremely rarely represented in autopsy samples. While
one may be tempted to establish clear cause-and-effect
relationships based on simpler cases, it may be the
cumulative impact of multiple pathogenic factors and
morbidities that determines TBI-related outcomes in
veterans of recent wars.
Conclusions
Brains of subjects with history of blast exposure show a
honeycomb pattern of APP (+) axonopathy, detected
here in the medial dorsal frontal white matter. Most of
these subjects had died of opiate overdose. Axonal
abnormalities in blast subjects are affiliated with reactive
microgliosis, a pattern that distinguishes them from
control cases of subjects who died of opiate overdose
but had no blast history. Blast-associated axonopathy is
also denser compared to that seen in opiate subjects and
appears to have some distinct microscopic features. It is
possible that blast and concurrent blunt TBI exposure as
well as particular antemortem circumstances, such as
opiate overdose and/or anoxia, may act in synergy toproduce the pattern of APP axonopathy observed here.
Our study establishes the background for future work
that should help clarify the previous mechanisms and
provide more definitive insights into the hundred-year
old problem of blast neurotrauma.
Additional files
Additional file 1: Figure S1. APP (+) axonopathy in the corpus
callosum of an index case with history of blast injury (Case 3, Table 1).
Enlarged, fusiform axons and axonal bulbs are indicated with arrows in
(a). (b) represents an enlargement of the blocked area in (a). It is unclear
whether these patches of classical DAI are associated with blast or, rather,
the concussion suffered as a result of assault 2 months prior to death.
Additional file 2: Figure S2. Neuropathological findings in the
cerebellum of an index case of blast injury (Case 3, Table 1) based on
staining with hematoxylin-eosin (a), Gallyas silver (b), and phosphorylated
neurofilament (c) or APP (d) immunohistochemistry. Note enlarged
eosinophilic (a) or argyrophilic (b) or phosphorylated neurofilament- and
APP-immunoreactive axon bulbs (c and d) in the Purkinje or granule cell layer
next to the cell bodies of Purkinje cells (arrows). APP immunohistochemistry
is especially sensitive in detecting these axonal abnormalities. Insets
represent magnifications of areas indicated with asterisks. As in the
case of classical axonal swellings with bulbs in Additional file 1: Figure S1, it
is unclear whether these profiles are associated with blast or the concussion
suffered from assault 2 months before death. GL, glomerular cell layer; ML,
molecular layer; PCL, Purkinje cell layer. Size bars: 5 μm (a) and 20 μm
(b, c and d).
Additional file 3: Figure S3. This case of mixed drug overdose (Case
11 in Table 1) , including opiates, is associated with severe axonal injury
that serves to illustrate better the type of axonopathy that occurs in drug
intoxication. Although the pattern is qualitatively similar to that in opiate
overdose, the intensity of labeling is unusually high. Note the straight
thin axons with periodic round swellings (arrows in b). Size bars: 50 μm.
Additional file 4: Figure S4. Patterns of APP (+) axonal pathology in
brain contusions. Case illustrated here (Case 19, Table 1) had hemorrhagic
contusion in ventromedial frontal lobe (a, arrows). Note the presence of
multiple APP (+) dilated, short axon stumps (circles) in the periphery of
hemorrhage (area indicated with an asterisk in a). Size bars: 500 (a) and 20
(b) μm.
Additional file 5: Figure S5. APP (+) axonal pathology in cases of
motor vehicle crashes is especially dense in medial dorsal frontal lobe
(a, arrows). Images here correspond to case 20 (Table 1). Axonal
abnormalities do not display perivascular patterns as in the case of blast
injuries (b; this is an enlargement of framed area in a). Size bars: 1 mm (a)
and 25 μm (b).
Additional file 6: Figure S6. Phosphorylated tau (AT8, CP13 and PHF1)
staining of three blast injury cases (g, h and i) compared with an established
dementia pugilistica case used here as positive control (a to f). Although
antibodies AT8, CP13 and PHF1 react intensely with phosphorylated tau
epitopes in the of the dementia pugilistica case (a-c; d-f are magnifications
of framed areas in a-c, respectively), no immunoreactivity is seen in the
hippocampus of Case 5 with history of blast exposure (g-i). Sections through
the temporal lobe of other blast cases were similarly negative and MC1
antibody did not stain brain tissues with a history of dementia pugilistica or
blast (data not shown). Size bars: 2 mm (a, b, c, g, h, and i) and 50 μm
(d, e, and f).
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